Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 33 | 50 | 0 | 7 | 6 |
| Gross Profit | 33 | 50 | N/A | 7 | 6 |
| Operating Expenses | 991 | 1,120 | 1,286 | 1,379 | 1,385 |
| Operating Income | -958 | -1,070 | -1,286 | -1,372 | -1,380 |
| Interest Expense | -7 | 0 | -61 | -42 | -60 |
| Other Income | 0 | 20 | 0 | 0 | 0 |
| Pre-tax Income | -952 | -1,050 | -1,225 | -1,330 | -1,320 |
| Net Income Continuous | -952 | -1,050 | -1,225 | -1,330 | -1,320 |
| Net Income | $-952 | $-1,050 | $-1,225 | $-1,330 | $-1,320 |
| EPS Basic Total Ops | -0.08 | -0.09 | -0.11 | -0.12 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.09 | -0.11 | -0.12 | -0.12 |
| EPS Diluted Total Ops | -0.08 | -0.09 | -0.11 | -0.12 | -0.12 |
| EPS Diluted Continuous Ops | -0.08 | -0.09 | -0.11 | -0.12 | -0.12 |
| EBITDA(a) | $-939 | $-1,056 | $-1,266 | $-1,353 | $-1,361 |